Coagulation factors are protein components of the blood which serve blood coagulation.
Search results 26 to 50 from a total of 90
| Name | Marketing Authorisation Holder | License Number | License Date | Further Information |
|---|---|---|---|---|
|
Fanhdi 1000 I.E. |
Grifols Deutschland GmbH |
10565a/97-3 | 12.08.1999 | |
|
Fanhdi 250 I.E. |
Grifols Deutschland GmbH |
10565a/97-1 | 12.08.1999 | |
|
Fanhdi 500 I.E. |
Grifols Deutschland GmbH |
10565a/97-2 | 12.08.1999 | |
|
OCTANINE F 500 |
OCTAPHARMA GmbH |
10501a/97-2 | 07.09.2000 | |
|
OCTANINE F 1000 |
OCTAPHARMA GmbH |
10501a/97-3 | 07.09.2000 | |
|
OCTAPLEX 500 |
OCTAPHARMA GmbH |
PEI.H.02312.01.1 | 14.03.2003 | |
ADVATE |
Takeda Manufacturing Austria AG |
EU/1/03/271 | 02.03.2004 | |
|
Fibrogammin 1250 |
CLS Behring GmbH |
PEI.H.03242.02.1 | 07.02.2005 | |
|
Fibrogammin 250 |
CSL Behring GmbH |
PEI.H.03242.01.1 | 07.02.2005 | |
|
Wilate 450 |
OCTAPHARMA GmbH |
PEI.H.01918.01.1 | 08.02.2005 | |
|
Wilate 900 |
OCTAPHARMA GmbH |
PEI.H.01918.02.1 | 08.02.2005 | |
|
Haemocomplettan P 2g |
CSL Behring GmbH |
PEI.H.03265.02.1 | 22.03.2005 | Rote-Hand-Brief: Haemocomplettan und Riastap (01.04.2019) |
|
Haemocomplettan P 1g |
CSL Behring GmbH |
PEI.H.03265.01.1 | 22.03.2005 | Rote-Hand-Brief: Haemocomplettan und Riastap (01.04.2019) |
|
Immuseven |
Takeda GmbH |
PEI.H.03341.01.1 | 28.11.2005 | |
|
Fanhdi 1500 I.E. |
Grifols Deutschland GmbH |
PEI.H.03436.01.1 | 24.08.2006 | |
Cofact 500 |
Prothya Biosolutions Netherlands B.V. |
PEI.H.03453.02.1 | 31.08.2007 | |
IMMUNINE 1200 I.E. |
Takeda GmbH |
PEI.H.03595.03.1 | 05.05.2008 | |
IMMUNINE 600 I.E. |
Takeda GmbH |
PEI.H.03595.02.1 | 05.05.2008 | |
|
Haemonine 1000 |
Biotest Pharma GmbH |
PEI.H.03626.03.1 | 02.01.2009 | |
|
Haemonine 500 |
Biotest Pharma GmbH |
PEI.H.03626.02.1 | 02.01.2009 | |
WILLFACT 1000 I.E. |
LFB-Biomedicaments |
PEI.H.03530.01.1 | 15.05.2009 | |
|
Riastap 1 g |
CSL Behring GmbH |
PEI.H.04771.01.1 | 03.12.2009 | Rote-Hand-Brief: Haemocomplettan und Riastap (01.04.2019) |
|
Wilate 500 |
OCTAPHARMA GmbH |
PEI.H.01918.03.1 | 22.12.2011 | |
|
Wilate 1000 |
OCTAPHARMA GmbH |
PEI.H.01918.04.1 | 22.12.2011 | |
|
NovoThirteen |
Novo Nordisk A/S, Denmark |
EU/1/12/775 | 03.09.2012 |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 520 in BAnz AT 22.08.2024 B6.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 22.08.2024
